-+ 0.00%
-+ 0.00%
-+ 0.00%

3 ASX Growth Stocks Backed By Insiders That Could Reward Patient Investors

Simply Wall St·07/15/2026 23:39:05
Listen to the news

With inflation pressures moving differently across regions and interest rate expectations constantly in focus, many investors are looking for companies where both analysts and insiders see room for growth. The Fast Growing Stocks With High Insider Ownership screener targets exactly that. It highlights businesses that pair strong growth potential with management teams that have meaningful skin in the game. This combination can help align your interests with those running the company. In this article you will see three stocks from the screener that stand out on growth and insider commitment, so you can decide whether any fit your watchlist.

Predictive Discovery (ASX:PDI)

Overview: Predictive Discovery is a West Africa focused gold company, centred on the Bankan Gold project in north east Guinea, with additional producing assets in the region and a head office in South Perth, Australia. It aims to identify, develop and operate gold deposits across West Africa, turning a large resource base into long term production.

Market Cap: A$3.24b

Predictive Discovery is drawing interest because it combines large scale West African gold assets with ambitious growth plans and substantial analyst expectations, yet still carries early stage risk. The merger that brought in producing mines at Kiniero and Nampala gives the company current gold output, while Bankan and Mansounia permits could add another hub if approvals and development progress as intended. At the same time, the business remains loss making, relies on external funding and has a short cash runway, while insiders have been selling and shareholders experienced dilution. For investors who are comfortable with permitting, jurisdiction and funding risks, the mix of production initiatives, analyst coverage and evolving governance could be worth a closer look.

Predictive Discovery’s push to turn a large West African resource base into long term production, while still loss making and reliant on funding, raises big questions about balance sheet resilience, so reviewing the Predictive Discovery financial health report

PDI Discounted Cash Flow as at Jul 2026
PDI Discounted Cash Flow as at Jul 2026

Telix Pharmaceuticals (ASX:TLX)

Overview: Telix Pharmaceuticals develops and commercialises radiopharmaceuticals that help doctors both detect and treat cancers, offering imaging agents and therapies for prostate, kidney and brain tumours, supported by its own manufacturing and distribution capabilities across several regions.

Operations: Telix generates most of its US$804.3m revenue from Precision Medicine at US$621.9m, with Manufacturing Solutions contributing US$245.1m and Therapeutics US$9.3m, while the United States accounts for US$784.9m of sales.

Market Cap: A$5.45b

Telix Pharmaceuticals stands out because it already has meaningful revenue from cancer imaging agents while also building a pipeline of therapeutics that could reshape its earnings mix if trials such as ProstACT Global and IPAX succeed. The company is still loss making and relies on higher risk external funding, and there is added uncertainty from an SEC subpoena, pricing pressure in PSMA imaging and trial execution risk. At the same time, Telix trades on a P/S of 4.7x that is lower than many biotech peers and has recently reaffirmed strong revenue guidance. In combination with its expanding theranostics partnerships, this gives investors a mix of current cash flow and high impact optionality that warrants a closer look.

Telix Pharmaceuticals has accelerating revenue and a pipeline that could reshape its earnings mix, yet the full story sits in the analysis report for Telix Pharmaceuticals, including one potential turning point investors often overlook.

ASX:TLX P/S Ratio as at Jul 2026
ASX:TLX P/S Ratio as at Jul 2026

Lindian Resources (ASX:LIN)

Overview: Lindian Resources is a Perth based explorer and developer focused on rare earths, bauxite and gold projects across Africa and Australia, with its flagship Kangankunde Rare Earths project in Malawi now moving from early mining activity toward first production. The company aims to supply rare earth concentrates used in high tech and clean energy applications, supported by new in house marketing and logistics capabilities in Singapore.

Market Cap: A$1.41b

Lindian Resources is drawing attention because Kangankunde is transitioning from a project on paper to a mine with first blasts completed, haulage and stockpiles underway and commissioning targeted for late 2026. Revenue and earnings are forecast to grow very quickly once production ramps. That growth story comes with real risks, including current losses that have been widening, high reliance on external funding, recent shareholder dilution and a board with no independent directors and limited tenure. For investors focused on fast growing stocks where insiders are heavily involved, the mix of a fully funded project, in house sales hub in Singapore and a high risk governance profile makes Lindian a rare earth developer that deserves a closer look.

Lindian Resources is moving quickly from plans to production, yet the full risk reward picture around Kangankunde is still easy to miss. For a deeper understanding, read the 1 key reward and 2 important warning signs (2 are major!)

ASX:LIN Earnings & Revenue Growth as at Jul 2026
ASX:LIN Earnings & Revenue Growth as at Jul 2026

The three stocks here are just a starting point. The full Fast Growing Stocks With High Insider Ownership screener surfaces 97 more companies that pair strong growth potential with substantial insider backing and analyst interest through the Fast Growing Stocks With High Insider Ownership screener. Use Simply Wall St to identify, filter and analyze the exact catalysts and narratives that matter to you so you can focus on the highest conviction ideas in this theme.

Take Control of Your Investment Journey

If Predictive Discovery or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Beyond These Picks?

Some of the sharpest breakouts start moving before the crowd notices, and the best entry points can disappear quickly. Scan fresh, under-the-radar ideas and consider getting in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.